CSTL
Castle Biosciences, Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Rating:C+
Company Profile
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Castle Biosciences, Inc.
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| 11,766 |
| $0.00 |
| 1 Jun 2026 | Harrison Miles | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | Cotton Rodney | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | Caple Kim | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | BRADBURY DANIEL | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | Cole G Bradley | director | A-Award | Acquired | 11,766 | $0.00 |
| 27 May 2026 | Cole G Bradley | director | M-Exempt | Acquired | 13,667 | $0.00 |
| 27 May 2026 | Cole G Bradley | director | M-Exempt | Disposed | 13,667 | $0.00 |
| 27 May 2026 | BRADBURY DANIEL | director | M-Exempt | Acquired | 13,667 | $0.00 |
| $1,001 - $15,000 |